846 related articles for article (PubMed ID: 12809998)
1. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
[TBL] [Abstract][Full Text] [Related]
2. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.
Hausdorff JM; Schaafsma JD; Balash Y; Bartels AL; Gurevich T; Giladi N
Exp Brain Res; 2003 Mar; 149(2):187-94. PubMed ID: 12610686
[TBL] [Abstract][Full Text] [Related]
3. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Vu TC; Nutt JG; Holford NH
Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
[TBL] [Abstract][Full Text] [Related]
4. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
[TBL] [Abstract][Full Text] [Related]
5. Gait variability in Parkinson's disease: levodopa and walking direction.
Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
[TBL] [Abstract][Full Text] [Related]
6. Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
Xie J; Krack P; Benabid AL; Pollak P
J Neurol; 2001 Dec; 248(12):1068-72. PubMed ID: 12013584
[TBL] [Abstract][Full Text] [Related]
7. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N
J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464
[TBL] [Abstract][Full Text] [Related]
8. Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
Hoskovcová M; Dušek P; Sieger T; Brožová H; Zárubová K; Bezdíček O; Šprdlík O; Jech R; Štochl J; Roth J; Růžička E
PLoS One; 2015; 10(10):e0139849. PubMed ID: 26443998
[TBL] [Abstract][Full Text] [Related]
9. Locomotor response to levodopa in fluctuating Parkinson's disease.
Moore ST; MacDougall HG; Gracies JM; Ondo WG
Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
[TBL] [Abstract][Full Text] [Related]
10. Deep brain stimulation effects on gait variability in Parkinson's disease.
Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of falls and associated features at different stages of Parkinson's disease.
Hiorth YH; Lode K; Larsen JP
Eur J Neurol; 2013 Jan; 20(1):160-6. PubMed ID: 22816560
[TBL] [Abstract][Full Text] [Related]
12. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
Ferreira F; Gago MF; Bicho E; Carvalho C; Mollaei N; Rodrigues L; Sousa N; Rodrigues PP; Ferreira C; Gama J
J Biomech; 2019 Jul; 92():98-104. PubMed ID: 31182234
[TBL] [Abstract][Full Text] [Related]
13. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
[TBL] [Abstract][Full Text] [Related]
14. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
Rochester L; Baker K; Nieuwboer A; Burn D
Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
[TBL] [Abstract][Full Text] [Related]
15. Risk of falling in Parkinson's disease at the Hoehn-Yahr stage III.
Kataoka H; Tanaka N; Eng M; Saeki K; Kiriyama T; Eura N; Ikeda M; Izumi T; Kitauti T; Furiya Y; Sugie K; Ikada Y; Ueno S
Eur Neurol; 2011; 66(5):298-304. PubMed ID: 22057308
[TBL] [Abstract][Full Text] [Related]
16. Gait analysis in advanced Parkinson's disease--effect of levodopa and tolcapone.
Shan DE; Lee SJ; Chao LY; Yeh SI
Can J Neurol Sci; 2001 Feb; 28(1):70-5. PubMed ID: 11252300
[TBL] [Abstract][Full Text] [Related]
17. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
[TBL] [Abstract][Full Text] [Related]
18. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
Plotnik M; Giladi N; Hausdorff JM
Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
[TBL] [Abstract][Full Text] [Related]
19. Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease.
Smulders K; Esselink RA; Weiss A; Kessels RP; Geurts AC; Bloem BR
J Neurol; 2012 Sep; 259(9):1840-7. PubMed ID: 22294215
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in the stride length-cadence relation in parkinsonian gait.
Morris M; Iansek R; Matyas T; Summers J
Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
